The skin is an important organ that not only covers the body but also performs various functions, such as temperature regulation, respiration, sensory functions, and immune functions. Therefore, if the functions of the skin are lost, the entire body would be affected and we would be unable to live. Recent studies have shown that hyaluronan is an important factor that maintains skin homeostasis by regulating skin development, proliferation, differentiation, regeneration, and anti-aging. On the other hand, it has been revealed that hyaluronan is also a risk factor that facilitates proliferation and metastasis of malignant skin tumors. Accordingly, it is expected that if the expression of hyaluronan in the skin can be artificially and freely regulated, it should be possible to maintain not only a person's skin health but also their general health. In this review, I outline the importance of hyaluronan, focusing on the correlation between skin hyaluronan and the pathophysiology of the skin.
differentiation, regeneration, and anti-aging, thereby maintaining skin homeostasis (1, 2) . On the other hand, hyaluronan is also a risk factor that facilitates proliferation and metastasis of malignant skin tumors (3) (4) (5) (6) . As such, hyaluronan regulates the functions of the skin in various ways. Accordingly, if it becomes possible to regulate the hyaluronan expression in the body intentionally and freely, it is expected that it would be possible to maintain not only a person's skin health but also their general health.
In this review, I outline the correlation between hyaluronan and the pathophysiology of the skin. I will do this by focusing on the correlation between hyaluronan and wound healing, particularly scarless wound healing, when the skin heals from damage without scar formation, aging, and the proliferation and metastasis of malignant skin tumors.
B. Hyaluronan Expressed in Skin
Hyaluronan, which is composed of repeated β-1,4-glucuronic acid-1,3-N-acetylglucosamine disaccharide units, is a non-sulfated glycosaminoglycan with a molecular weight of over 1,000,000 Da ( Fig. 1) (7) . The amount of hyaluronan present in the skin is equivalent to 50% or more of the total amount of hyaluronan in the body (8, 9) . Hyaluronan is abundant in the extracellular matrix of the epidermis and dermis that comprise the skin (Fig. 2) . Epidermal keratinocytes, melanocytes, and dermal fibroblasts are the major cells that synthesize hyaluronan. The cell membrane of each cell contains 3 types of hyaluronan synthases (HAS) (HAS-1, HAS-2, and HAS-3) that synthesize hyaluronan (10) (11) (12) (13) . Accordingly, under a microscope, abundant hyaluronan distribution surrounding the cells, or in other words a hyaluronan-rich matrix, is observed ( Fig. 1) (14, 15) . Subsequently, hyaluronan moves toward the extracellular matrix and regulates the functions and pathophysiology of the skin.
F i g . 1 . C o m p o s i t i o n o f h y a l u ro n a n ( a ) a n d a microscopic view of hyaluronan rich matrix (b).

C. Correlation between Hyaluronan Expression and Scarless Wound Healing
In adult mammals, with some exceptions such as the liver, organs do not regenerate once damaged. Similarly, the skin heals with scar formation once it is deeply injured below the dermal level. This wound healing mechanism is referred to as postnatal wound healing. In the scarred area, the number of collagen fibers increase and become irregularly arranged, resulting in fibrosis. In addition, the numbers of elastic fibers decrease and diminish. As such, the skin elasticity declines, the skin is hardened, and normal functions are lost. On the other hand, in the fetal phase of mammals, scarless wound healing, by which the skin regenerates completely, occurs. Even if the skin is severely damaged, the skin perfectly regenerates without scar formation (16) . In rats, because scarless wound healing occurs until the 16th day of the fetal period, no scars are formed in this period. After the 18th day of the fetal period, scarless wound healing is diminished, resulting in the formation of scars (17) . For mice, scarless wound healing changes to postnatal wound healing between the 13th and 14th day of the fetal period for the epidermis and between the 16th and 17th day of the fetal period for the dermis (18) . In monkeys, wounds heal without scar formation until the 75th day of the fetal period; however, scars are formed after the 85th day (19) . 

One of the characteristics of scarless wound healing is that hyaluronan in the skin is present for a longer period and at a higher concentration compared to postnatal wound healing, and it is believed that this is one of the reasons why scars are not formed. Indeed, when a wound is created in the skin of a fetal rat, hyaluronan is immediately and excessively synthesized and slowly degraded. On the other hand, for postnatal wound healing, hyaluronan is synthesized relatively early but also quickly degraded (20) . In addition, in organ cultures of the legs of adult mice in highconcentration hyaluronan solutions, scar formation on the skin is moderate and the wound is immediately closed (21) . When hyaluronidase (Hyal), a hyaluronan-degrading enzyme, is administered to injured skin to decrease the hyaluronan content, scar formation becomes prominent (22) . We also found that, in hyaluronan knockdown mice (described in detail below), scar formation becomes prominent. Furthermore, it is well known that scars and wrinkles can be healed by injecting hyaluronan into the skin.
Kennedy et al. reported that in scarless wound healing, dermal fibroblasts biosynthesize a large amount of hyaluronan; however, the difference to the amount of hyaluronan in postnatal wound healing is small. In addition, no differences were observed in the expression level of HAS genes between the mechanisms of scarless wound healing and postnatal wound healing (23) . However, the reactivity of dermal fibroblasts to inflammatory cytokines [tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β)] is different in each mechanism. TNF-α and IL-1β increase the hyaluronan biosynthesis in both scarless wound healing and postnatal wound healing; however, the hyaluronan biosynthesis increased to a greater extent in scarless wound healing The expression of the HAS-1 gene is facilitated by both TNF-α and IL-1β, whereas the expression of the HAS-3 gene is facilitated by TNF-α only; the promoting effect is stronger in postnatal wound healing (23) . Since there have been no reports on the relationship between the expressions of Hyal genes and scarless wound healing, nothing definitive can be said. However, based on the fact that there is no difference in the expressions of HAS genes and the reactivity of inflammatory cytokines in hyaluronan biosynthesis and the expression of HAS genes are different between both wound healing mechanisms, the high hyaluronan content in the skin during scarless wound healing suggests, at the very least, that 2 mechanisms, one in which the expression of HAS genes is posttranscriptionally regulated and another one in which the expression of Hyal genes is suppressed, are present in scarless wound healing. In addition, it has recently been proven that hyaluronan suppresses the platelet functions of the fetus and it is believed that inflammation that occurs during skin damage suppresses the platelet functions, thus making it possible to heal wounds without forming scars (24) .
The homeobox genes MSX-1, MSX-2, PRX-2, and MOX-1, which are essential for morphogenesis, are strongly expressed in scarless wound healing, thus suggesting that each gene is an important regulatory factor for scarless wound healing (25, 26) . In addition, the expression of the homeobox gene HOXB13 is low in scarless wound healing but high in postnatal wound healing. When the skin of a HOXB13 knockout mouse is damaged, the wound is quickly closed without scar formation. Furthermore, the skin of these mice contains abundant hyaluronan, which also strongly suggests that hyaluronan is an important regulatory factor in scarless wound healing (27) .
The regulatory mechanisms underlying hyaluronanmediated scarless wound healing are still unknown and require further detailed analysis. In particular, it is important to analyze the timing of the transition from scarless wound healing to postnatal wound healing. It is expected that by identifying hyaluronan-related key factors that regulate the transition period, it will be possible to rapidly promote skin regenerative medicine without leaving scars and to completely treat skin damage that leaves scars, such as burns or trauma.
D. Correlation between Hyaluronan Expression and Skin Aging
Skin aging is classified into 2 types: intrinsic aging and photo-aging. Intrinsic aging of the skin is inevitable as in the cases of other organs, and it is strictly regulated by various factors such as aging-related genes, hormones, and active oxygen. It is clinically characterized by fine wrinkles, dryness, and thinning observed in the unexposed areas of the skin, such as the body trunk (28) . Photo-aging refers to skin-specific aging that occurs under ultraviolet (UV) radiation. Two types of UV radiation that arrive at the surface of the earth, UVA and UVB, cause the degeneration of body components such as DNA, proteins, lipids, and carbohydrates of the skin, and change the level of expression of cytokines and growth factors, and thereby causing a decline in skin function. In addition, the degenerated components themselves acquire carcinogenicity, leading to the development of malignant skin tumors such as basal cell carcinoma, squamous cell carcinoma, and melanoma. Due to the loss of strength and elasticity of the skin, deep wrinkles, spots, and skin malignancies appear in exposed areas such as the face and dorsal surface of the hand (28, 29) . As such, the clinical symptoms are different between intrinsic aging and photo-aging; however, each type of aging does not occur independently, and photo-aging occurs in addition to intrinsic aging.
In aged skin, particularly photo-aged skin, the hyaluronan content is significantly decreased. On the other hand, by injecting hyaluronan into this skin, the symptoms of photo-aging, such as wrinkles, diminish. Therefore, hyaluronan is recognized as a substance that can suppress aging, or as an anti-aging substance. Some studies on the effect of UV radiation on the expression of hyaluronan have recently been published, and the regulatory mechanisms of hyaluronan for photo-aging have been gradually revealed.
Averbeck et al. performed UVB radiation of human epidermal keratinocytes (HaCaT) and dermal fibroblasts and analyzed the expression of hyaluronan and hyaluronan-related genes shortly after irradiation, The expression of HAS genes in each cell was promoted 24 hours after irradiation. In addition, the expression of Hyal genes was not changed in HaCaT cells but was increased in dermal fibroblasts. Although the amount of hyaluronan production declined in both cells 3 hours after irradiation, it returned to normal levels in HaCaT cells after 24 hours, whereas it remained lower than normal in dermal fibroblasts. In addition, when human skin was irradiated with UVB, the hyaluronan content of the epidermis increased after 24 hours, whereas it decreased in the dermis (30). Calikoglu et al. irradiated the skin of mice with UVA or UVB and reported that after 2 hours, the hyaluronan production and the expression of the hyaluronan receptor, CD44, in the epidermis were suppressed but returned to normal after 24 hours (31).
Dai et al. repeatedly irradiated the skin of mice with UVB over a long period of time (3 times/week, 182 days) and demonstrated that the expression of HAS genes was suppressed, resulting in a marked decrease in the dermal hyaluronan content (32) . They also reported that the expression of Hyal and CD44 did not vary. In addition, they demonstrated that the expression of transforming growth factor β1 (TGF-β1), which promotes the expression of HAS1 and HAS2, was also suppressed by UVB radiation, and considered this observation as one of the causes of the decrease in dermal hyaluronan content (32) .
UV rays act on the hyaluronan expression in various ways depending on the irradiated area, amount, time, and duration after irradiation, indicating that the regulation of hyaluronan by UV rays is complicated. However, based on the fact that wrinkles are formed through exposure to UV irradiation over many decades, it is necessary to focus particularly on the results of repetitive UV irradiation experiments conducted over a long period of time. Therefore, long-term UV irradiation decreases the amount of hyaluronan production by suppressing the expression of HAS genes, and as a result, skin elasticity is lost. In addition, because an even stronger external force is imposed on the forehead and the corners of the eyes, it can be inferred that deep wrinkles are easily formed (Fig. 3) .
Shortly after UV irradiation, the expression of hyaluronan and HAS genes in the skin is promoted. These results suggest that this is because the symptoms of acute inflammation of the skin caused by UV light are still severe, and the secretion of inflammatory cytokines such as TNF-α and IL-1β is therefore increased, the expression of HAS genes is temporally promoted, and, as a result, the rate of hyaluronan production may be increased.
E. Correlation between Hyaluronan and Malignant Skin Tumor
Hyaluronan is a risk factor that promotes the proliferation and metastasis of malignant tumors. The expression of hyaluronan and its receptor CD44 increases in many cases of malignant tumor, suggesting that it is significantly related to proliferation and metastasis.
4-Methylumbelliferone (MU) inhibits the binding of glucuronic acid, which is an HAS substrate, with another substrate of N-acetylglucosamine, and thereby inhibits the synthesis of hyaluronan (Fig. 4) (33-35) . We analyzed hyaluronan knockdown cells or animals generated by administering MU, as well as the effect of MU on the metastasis of malignant melanomas, which is one of the malignant tumors that develop in the skin at a high frequency. We demonstrated that, when treating the melanoma cells (B16F10 cells) of a mouse with MU, the hyaluronan-rich matrix on the cell surface is diminished, and the amount of hyaluronan translocating from there to the extracellular matrix is also decreased (Fig. 4) (15) . However, MU did not affect the synthesis of components of the extracellular matrix such as other glycosaminoglycans, collagen, or laminin (15) .
Next, we analyzed the effect of MU on the adhesion of In contrast, the number of adhered cells in a hyaluronan-coated culture dish was increased (Fig. 5) . Thus, it was demonstrated that when hyaluronan synthesis is inhibited by MU, adhesion of the B16F10 cells declines (15) . In contrast, the number of adhered cells in a hyaluronan-coated culture dish was increased. (B) The influence of MU on locomotion was investigated using the Boyden chamber method. The number of cells passing through from the upper chamber to the lower chamber was decreased in a dose-dependent manner in the presence of MU. On the other hand, when adding hyaluronan to the lower chamber, the number of cells that passed through was increased. 
MU(-)
We analyzed the effects of MU on cell locomotion using the Boyden chamber method. As a result of adding B16F10 cells treated with MU to the upper chamber to count the number of cells that passed through the filter membrane to the lower chamber, the number of cells passing through was decreased in a dose-dependent manner. On the other hand, when adding hyaluronan to the lower chamber, the number of cells that passed through was increased. Accordingly, we demonstrated that MU also suppresses locomotion (Fig. 5)  (15) .
The declines in adhesion and locomotion of the B16F10 cells caused by MU suggest that MU suppresses metastasis of the B16F10 cells. Therefore, we analyzed the effects of MU on the metastasis of B16F10 cells in mice. In this experiment, it was necessary to analyze the effects of MU on both hyaluronan synthesized by the B16F10 cells and hyaluronan synthesized by the organs to which the cells metastasized. Firstly, B16F10 cells that were treated with MU and had no hyaluronan on the cell surface were injected into mice via the tail vein. MU-untreated B16F10 cells were observed to metastasize to the liver and the lungs at a high frequency; however, metastasis was markedly suppressed in MU-treated B16F10 cells (Fig. 6) (36) . Next, the B16F10 cells were injected into hyaluronan knockdown mice that had been orally administered MU in advance. In the control Fig. 6 . Effect of MU on the formation of metastatic nodules on the liver. B16F10 cells that were treated with MU were injected into mice via the tail vein. The MU-untreated B16F10 cells metastasized to the liver at a high frequency, whereas metastasis of the MU-treated B16F10 cells was markedly suppressed. B16F10 cells were also injected into hyaluronan knockdown mice that had been orally administered MU. In the control mice, metastasis of the B16F10 cells was observed at a high rate, whereas metastasis in the MU-treated hyaluronan knockdown mice was markedly suppressed. mice, metastasis of the B16F10 cells was observed at a high rate, whereas it was markedly suppressed in the hyaluronan knockdown mice. Accordingly, hyaluronan in both the B16F10 cells and in the organs promoted metastasis, strongly indicating that MU could be a new anticancer agent (Fig. 6 ) (36) . We also analyzed the effects of MU on the metastasis of other types of malignant tumor such as pancreatic cancer, and demonstrated that MU can suppress the metastasis of any tumor (37, 38) . MU is an agent that has frequently been used as a bile secretion promoter and its safety has been established. Therefore, it can be concluded that it is highly possible for MU to be orally administered as an anticancer agent to prevent the recurrence and metastasis of malignancies. In addition, we also analyzed the effects of various MU-derivatives for metastasis suppression and demonstrated that metastasis is a strongly suppressed by derivatives with more methyl groups and hydroxyl groups than MU (38, 39) .
Recently, several studies have reported that hyaluronan signals were blocked to treat malignant melanoma, and these reports have been drawing attention. Ahrens et al. reported that the hyaluronan receptor, CD44, is a mediator for proliferation and metastasis of malignant melanoma (40) . Furthermore, it has been demonstrated that proliferation and metastasis of tumors can be suppressed by administering anti-CD44 antibodies to the body, and the clinical application of this method has been rapidly promoted (41) .
IL-2 therapy, in which IL-2 is administered to the body, is an extremely effective treatment for malignant melanoma. However, IL-2 therapy causes vascular leak syndrome (VLS), which can be fatal and cause multiple organ failure and shock (42) . Guan et al. demonstrated that by administering the hyaluronan-specific binding protein Pep-1, which firmly binds to hyaluronan on the cell surface, to the body, it is possible to inhibit the interaction of hyaluronan with CD44, thereby suppressing metastasis of malignant melanomas (43) . Furthermore, they found that Pep-1 administration also suppressed the onset of VLS and maintains the effects of IL-2 (43). In the future, it is expected that IL-2 therapy with the concomitant use of Pep-1 can be a safe and highly effective treatment for malignant melanomas.
Malignant melanomas proliferate rapidly, metastasize easily, and have an extremely unfavorable clinical prognosis. One of the factors determining this prognosis is hyaluronan, and optimal regulation of hyaluronan expression will be a key for sustaining life. There are high expectations for the treatment effects of MU, anti-CD44 antibodies, and Pep-1, which are substances that suppress the expression of hyaluronan or hyaluronan signals, for malignant melanoma. In addition, anti-CD44 antibodies have already been clinically applied as a treatment agent. Accordingly, we believe that in the future, if optimal methods of administration of these substances are established, the treatment outcomes for malignant melanomas will improve dramatically.
F. Comments
When asked "What is the role of hyaluronan in the skin?" in the past, the answer would have been "To prevent dryness of the skin." It has now been revealed that hyaluronan is an important substance that regulates various mechanisms such as skin development, differentiation, regeneration, aging/ anti-aging, and carcinogenesis. However, these studies have only just begun, and as shown in this study, the details are still unknown. Accordingly, it is necessary to clarify the molecular mechanisms, which is an urgent task for clinical medicine. If it becomes possible to freely regulate the expression of hyaluronan in the skin in future, it would be possible to maintain skin that is forever young, beautiful, and sturdy, as well as skin that does not develop malignancies. This is important for general health because the skin is essential for maintaining general homeostasis and it is impossible for humans to live without the skin. For such reasons, we believe that it is necessary to promote further studies on hyaluronan.
